Report cover image

Atopic Dermatitis: 68-Market Drug Forecast and Market Analysis - Update

Publisher GlobalData
Published Jan 29, 2026
Length 20 Pages
SKU # GBDT20881428

Description

Atopic Dermatitis: 68-Market Drug Forecast and Market Analysis - Update

Summary

This report covers the 68 geographical markets and provides an Excel-based forecast model for the Atopic Dermatitis disease market through 2033.

GlobalData estimated that the atopic dermatitis market was $10.8 billion across the 68MM in 2023. By the end of the forecast period in 2033, sales across these markets will reach $26.2 billion, increasing at a compound annual growth rate (CAGR) of 9.3%. This strong growth will be fuelled by driven by the launch of seven late-stage pipeline agents in the 7MM, increase in treatment options for all age groups and severities, high diagnosed prevalence of atopic dermatitis and high treatment rates across all markets in the 7MM, and novel mechanisms of action anticipated to enter the atopic dermatitis market over the forecast period.

Scope
  • Overview of AD - including epidemiology, disease etiology and management.​
  • Annualized atopic dermatitis therapeutics market revenue, cost of therapy per patient, and treatment usage patterns forecast from 2023 to 2033.
  • Key topics covered include assessment of marketed and pipeline therapies, unmet needs, current and future players and market outlook for the US, 5EU, and Japan over the 10-year forecast period.​
  • Pipeline analysis: Emerging novel trends under development, and detailed analysis of late-stage pipeline drugs.​
  • Analysis of the current and future market competition in the global AD therapeutics market. Insightful review of the key industry drivers and barriers.
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies, using a detailed overview of current pipeline products and technologies to identify companies with the most robust pipelines.​
  • Develop business strategies by understanding the trends shaping and driving the atopic dermatitis (AD) therapeutics market.​
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the seven-market AD market in the future.​
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.​
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.​
  • Track drug sales in the seven-market AD therapeutics market from 2023-2033.​
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.​
Please note:this is delivered as a Zipfile.​

Table of Contents

20 Pages
1 Executive Summary
1.1 Overview
1.2 68M summary statistics
1.3 Key 7MM events driving the 68M forecast extrapolation
2 Appendix
2.1 Abbreviations
2.2 Methodology
2.2.1 Patient-based forecast methodology
2.2.2 68M forecast extrapolation methodology
2.3 Primary research - key opinion leaders interviewed for this report
2.4 Primary research - prescriber survey
2.5 About the authors
2.5.1 Analyst
2.5.2 Managing analyst
2.5.3 Therapy area directors
2.5.4 Epidemiologist
2.5.5 Epidemiology reviewers
2.5.6 Vice President of Disease Intelligence and Epidemiology
2.5.7 Global Head of Pharma Research, Analysis, and Competitive Intelligence
3 About GlobalData
Contact Us
List of Tables
Table 1: Atopic Dermatitis market size across the 68M - 7MM versus 61M
Table 2: Atopic Dermatitis market size across the 68M - by geographical region
Table 3: Atopic Dermatitis, key events occurring in the 7MM driving forecast trajectory in the 68M
Table 4: High-prescribing physicians (non-KOLs) surveyed, by country
List of Figures
Figure 1: Atopic Dermatitis market size across the 68M - 7MM versus 61M
Figure 2: Atopic Dermatitis market size across the 68M - by geographical region

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us